TBPH FY 2020 Earnings — Theravance Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

TBPHTheravance Biopharma, Inc.

$697M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$72M-2.1% YoY

Gross Profit

$72M100.0% margin

Operating Income

-$298M-414.2% margin

Net Income

-$278M-386.9% margin

EPS (Diluted)

$-4.46

Cash Flow

Operating Cash Flow

-$250M

Free Cash Flow

-$257M

Stock-Based Comp.

$63M

Balance Sheet

Total Assets

$469M

Total Liabilities

$773M

Stockholders' Equity

-$304M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$72M	$73M	-2.1%
Gross Profit	$72M	$73M	-2.1%
Operating Income	-$298M	-$252M	-18.1%
Net Income	-$278M	-$236M	-17.6%